SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

InMed Pharmaceuticals Q3 EPS $(0.02), Same YoY

InMed Pharmaceuticals (TSX:IN) reported quarterly losses of $(0.02) per share. This is unchanged from the same period last year.

Benzinga · -

InMed Pharmaceuticals (TSX:IN) reported quarterly losses of $(0.02) per share. This is unchanged from the same period last year.